Professional
Added to YB: 2025-09-01
Pitch date: 2025-08-26
SNOA [bullish]
Sonoma Pharmaceuticals, Inc.
-25.05%
current return
Author Info
Trickle Research is an independent microcap research firm. Visit the website.
Company Info
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
Market Cap
$7.5M
Pitch Price
$4.79
Price Target
12.00 (+234%)
Dividend
N/A
EV/EBITDA
-1.46
P/E
-1.85
EV/Sales
0.31
Sector
Pharmaceuticals
Category
growth
Allocation Increase & Post-Split Target Adjustment - Sonoma Pharmaceuticals, Inc.
SNOA: Specialty pharma w/ stabilized hypochlorous acid tech. New partnerships: WellSpring distributing diaper rash product to 3,600 Walmart stores + Amazon; Medline distributing surgical irrigation to US hospitals. Q1F26 best revenue since pandemic, highest inventory in years signals growth expectations. $12 price target, allocation raised to 5.
Read full article (9 min)